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Management of brain injury can pose
enormous challenges to the health team. There are
many studies aimed at discovering or developing
pharmacotherapeutic agents targeted at
improving outcome of head-injured patients. This
paper reviews the role of oxidative stress in
neuronal loss following traumatic brain injury and
presents experimental and clinical evidence of the
r o l e o f e x o g e n o u s a n t i o x i d a n t s a s
neuroprotectants.
We reviewed published literature on
reactive oxygen species and their role in
experimental and clinical brain injuries in journals
and the Internet using Yahoo and Google search
engines.
Traumatic brain injury causes massive
production of reactive oxygen species with
resultant oxidative stress. In experimental brain
injury, exogenous antioxidants are useful in limiting
oxidative damage. Results with clinical brain injury
are however more varied.
Oxidative stress due to excessive
generation of reactive oxygen species with
consequent impairment of endogenous
antioxidant defence mechanisms plays a
significant role in the secondary events leading to
neuronal death. Enhancement of the defence
mechanisms through the use of exogenous
antioxidants may be neuroprotective, especially if
the agents can penetrate cell membranes, are able
to cross the blood-brain barrier and if they are
administered within the neuroprotective time
window.
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Introduction
Traumatic Brain Injury (TBI) is a worldwide
problem , and its management can pose
enormous challenges to the medical team as well
as significantly stretch hospital resources
(including manpower, facilities, etc). It is
predominantly a “disease” of young persons and
has assumed such immense proportions that the
World Health Organisation (WHO) has placed it as
a 21st century epidemic equivalent only to malaria
and HIV/AIDS . The last few decades have
witnessed tremendous advances in virtually every
aspect of TBI, but perhaps the area where this has
been most remarkable is in the understanding of
the pathophysiological processes attending the
injury. Though many questions remain
unresolved, research studies have shed much light
on the accompanying events. It is now believed
that even though the initial injury, which may be
focal or diffuse, may produce neuronal damage or
death, it also sets off a cascade of other events
including the effects of hypoxia, release of
endogenous excitatory amino acids (such as
glutamate), production of pro-inflammatory
substances as well as the generation of free
radicals .
Experimental studies have shown that one of the
key participants in the events leading to secondary
brain damage is oxidative stress (OS), which is
believed to be the common pathway for diverse
brain disorders ; and it is thought that defining its
role in central nervous system injury could help
with the development of novel, clinically
applicable therapies . Thus, several of the ongoing
research efforts aimed at discovering measures
targeted at improving the outcome of patients
following TBI are the direct consequences of the
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This brief review deals with the sources and nature
of reactive oxygen species, their role in traumatic
brain injury and the endogenous antioxidant
defence mechanisms. It also summarises new
pharmacological strategies some of which are at
various stages of clinical trial, and presents
experimental and clinical evidence of the role of
exogenous antioxidants as neuroprotectants in
traumatic brain injury. The need for more clinical
trials is highlighted.
Free radicals are highly reactive compounds which
are mostly generated during cellular respiration
and normal metabolism . Their possession of
unpaired electrons in their outer shell causes them
to be more reactive than their corresponding non-
radicals. This is because they act as electron
acceptors, and essentially "steal" electrons from
other molecules and thereby modify their chemical
structures – an action which is referred to as
oxidation .
Free radicals are liberated from a variety of sources,
including inflammatory cells, dysfunctional
mitochondria and excitotoxic mechanisms which
are stimulated by increased glutamate and
aspartate concentrations . Superoxide radical is the
most commonly occurring cellular free radical and
it is produced when an oxygen molecule gains one
electron from another compound .
There is a vast amount of evidence implicating
oxygen-derived free radicals as well as other high-
energy oxidants as playing mediatory roles in
diverse pathological conditions . They have also
been shown to be key contributors in the secondary
events following brain injury ; and the
formation of the oxygen radical, superoxide anion,
is believed to be one of the final events of several
metabolic pathways in the cascade which leads to
delayed neuronal death after traumatic or
ischaemic brain injury . Cellular injury caused by
reactive oxygen species (including free radicals,
peroxides and oxygen ions), is believed to occur as a
result of oxidation of polydesaturated fatty acids in
lipids, oxidation of amino acids in proteins, damage
of the DNA and inactivation of specific enzymes by
oxidation of co-factors .









Oxygen free radicals are produced continuously
in tissues, and even though they are considered
to be destructive agents, they can sometimes be
useful. It is believed that they act as secondary
messengers in intracellular signalling cascades
which are responsible for the induction and
maintenance of the oncogenic phenotype of
cancer cells. They may also function as anti-
tumourigenic species .
Normally, a state of equilibrium exists between
tissue oxidant and antioxidant activities . This
balance can, however, be upset as a result of
excessive free radical generation, depletion of
endogenous antioxidants or failure to repair
oxidative injury induced by reactive oxygen
species. The resultant condition is referred to as
oxidative stress (OS) . Enhanced oxidative
stress associated with increased production of
free radicals has been implicated in the
disruption of neuronal homeostasis induced by
traumatic brain injury .
Traumatic brain injury (TBI) leads to massive
production of reactive oxygen species (ROS),
which in turn mediate further damage via various
cellular molecular pathways, including damage to
cellular components like lipids, proteins and
nucleic acids6, with neuronal death occurring
as a result of impairment of cellular calcium
homeostasis, tissue acidosis, and oxidative
stress . OS is also thought to, at least in part,
initiate or influence autophagy – a process
whereby cellular components are digested by
enzymes within the same cell . Experimental
data indicate that the destructive oxidative
events following TBI reach their peak within the
first 24 hours of injury, and that the brain damage
that occurs as a result of the impact can be the
cause of death or irreversible permanent
disabilities in affected patients . The degree of
oxidative injury in clinical TBI is, however, not yet
completely understood .
Antioxidants are compound whose actions
include: inhibition of the formation of reactive
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for catalysis of their generation, and scavenging of
reactive oxygen species or their precursors. They
inhibit other oxidation reactions by being oxidized
themselves. Endogenous antioxidant scavenger
mechanisms help to defend cells against oxidative
injury . Two major groups of these compounds
are recognised: antioxidant enzymes (such as
superoxide dismutase, catalase and glutathione
peroxidise), and low molecular weight antioxidants
(LMWA) The latter group contains directly acting
agents (such as ascorbic acid, lipoic acid,
and carotenoids) and
indirectly acting antioxidants (e.g. chelating
agents) .
The high rate of oxidative metabolism in the normal
brain and its elevated levels of polyunsaturated
lipids (which are the target of lipid peroxidation)
render it particularly vulnerable to oxidative
stress . Oxidative damage is, however,
prevented by the actions of endogenous
antioxidants. Free radicals, especially superoxide
and some non-radicals, (e.g. hydrogen peroxide),
can be generated in such large quantities that the
endogenous protective enzyme systems are
overwhelmed . When there is brain trauma, the
regulatory mechanisms are also progressively
compromised and they may either be eliminated
altogether or even be converted to become pro-
oxidant . Environmental as well as genetic
factors are thought to play some role in the
reduction in the endogenous antioxidant defence
system and thereby contribute to the evolution of
oxidative stress . Experimental studies have shown
that enhancing this endogenous antioxidant
defence mechanism may be neuroprotective during
injury.
There are several research studies on the use of
exogenous antioxidants in TBI. Most of these are
hinged on the belief that the free radicals (which are
by-products of increased neurotransmitter
activity), are the agents actually responsible for
neuronal death . A number of therapeutic trials
based the ability of antioxidants to scavenge free
radica ls have been attempted in both












It is thought that antioxidants that would
effectively cross the blood-brain barrier and
penetrate into the damaged tissue may help to
maintain the redox status of the neurons,
decrease ROS-associated neuronal damage and
thus reduce neurological impairment and
disability .
Furthermore, to be effective, such antioxidant
should be given within the neuroprotective
"time window", which is the time interval
between the trauma event and irreversible
neuronal loss. When given during this period,
they may be expected to significantly reduce or
prevent cerebral damage . However, majority
of the currently available antioxidants are not
able to cross the blood-brain barrier from the
systemic circulation, thereby limiting their
efficacy as neuroprotectants.
Animal studies have shown that antioxidant
administration interrupts the sequence of brain
injury responses . Results with clinical TBI
have, however, been more varied . In some
studies involving TBI patients, the exogenous
antioxidants were reported to have no beneficial
effects. Young et al carried out a randomized,
parallel, placebo-controlled, third-party-blind,
multicenter trial of pegorgotein (a scavenger of
oxygen-derived free radicals), with the aim of
evaluating its effects on neurologic outcome of
patients with severe closed head injury. They
reported that even though pegorgotein was well
tolerated at 3 months after injury, there was no
significant statistical difference in neurologic
outcome between the pegorgotein and the
placebo-treated groups. However, there was no
increase in the mortality or disability states
among the patients given pegorgotein .
Other studies have shown that the neutralisation
of ROS by endogenous or exogenous
antioxidants has a protective effect on brain
tissue. The study by Shohami et al demonstrates
that the brain responds to ROS by increasing low
molecular weight antioxidants and that among
head-injured patients, the degree of the
response correlates well with clinical recovery:
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Similarly, in a randomised controlled Phase II trial to
evaluate the safety and efficacy of polyethylene
glycol-conjugated superoxide dismutase (PEG-
SOD) in severely head-injured patients, Muizelaar
et al reported significantly improved outcome in
the groups of patients treated with PEG-SOD as
compared with their placebo-treated groups . It
thus appears from these reports that there might
some promise in the use of exogenous antioxidants
in situations where the natural defence
mechanisms are compromised.
Uric acid (UA), which is one of the most abundant
aqueous antioxidants in humans is thought to
account for as much as two-thirds of all free radical
scavenging capacity in plasma (being found to be
particularly effective in quenching hydroxyl,
superoxide and peroxynitrite radicals) .
Experimental data have shown that local uric acid
concentrations are significantly increased in acute
traumatic brain injury ; and that early elevation of
UA, during or shortly after TBI and other cerebral
disorders mediated by free radicals, could confer
significant protection against the occurrence of
neurological deficits .
Ascorbic acid is known to be a very effective free
radical scavenger. It is not synthesised in humans
and as such, it must be obtained from dietary
sources. Even though its exact functions are not
known, it is believed that ascorbic acid can
neutralise reactive oxygen species such as
hydrogen peroxide which are produced during
TBI . In addition to its direct antioxidant effects,
ascorbic acid is also a substrate for the antioxidant
enzyme ascorbate peroxidise.
Melatonin is also a very potent antioxidant and
direct free radical scavenger that is particularly
efficacious because of its ability to penetrate cell
membranes as well as cross the blood-brain barrier.
It protects against oxidative damage at the level of
cells, tissues, organs and organisms. Its
antioxidative mechanisms seem different from
those of the classical antioxidants in that whereas
the latter undergo redox cycling and thus have the
potential to promote oxidation as well as prevent it,







Melatonin has been referred to as a terminal (or
suicidal) antioxidant because once oxidized, it
cannot be reduced to its former state because it
forms several stable end-products upon reacting
with free radicals .
Another group of antioxidants that has received
tremendous attention during the last few years
are the cannabinoids. These include compounds
which have similar structure with the
psychoactive components in cannabis, as well as
agents which activate the cannabinoid receptor
system in the body. Researchers have shown that
the cannabinoids are effective neuroprotectants
in experimental animals. Some of them, such as
the synthetic cannabinoid, dexanabinol (HU-
211), are at various stages of clinical trials. The
results have so far been promising. In a
prospective, randomised, double-blind, placebo-
controlled, multicenter study including six Israeli
neurosurgical intensive care units, dexanabinol
was shown to be safe and well tolerated in
severely headed-injured patients. The treated
patients achieved significantly better intracranial
pressure/cerebral perfusion pressure control.
The authors also observed a trend towards faster
and better neurologic outcome. While
confirming the strong cerebroprotective effect of
dexanabinol, the study by Shohami et al also
showed a therapeutic window of about 4
hours .
Dexanabinol is a promising drug which does not
produce psychotrophic or other adverse side
effects associated with some of the earlier drugs
of its type . Though the neuroprotective effect of
the cannabinoids is thought to be due to their
strong antioxidant property, some researchers
consider that this attribute alone is unlikely to
account for all of the protection. It is thought that
an additional mechanism whereby they provide
their protective effect is by the inhibition of the
glutamate system in the brain thereby
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Conclusion
Traumatic brain injury remains a significant
problem worldwide. Oxidative stress plays a
significant role in neuronal death following injury
due to the progressive compromise of
endogenous antioxidant defence systems. The
neutralisation of reactive oxygen species by
endogenous or exogenous antioxidants has a
protective effect on the brain.
Consequently, the discovery and development of
antioxidant agents is one of the most promising
approaches in the search for more effective
treatment of TBI. Several potentially useful agents
have been identified, and even though the effect
of many of them in clinical TBI is still controversial,
some have shown some promise. More clinical
trials are however needed to resolve some of the
ongoing controversy.
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